Nervgen Pharma Corp. SEC filings NGEN

Nervgen Pharma Corp. has 41 filings in SEC EDGAR's recent list, going back to Sep 20, 2018. Its latest annual report, Form 40-F, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Sep 25, 2026. The company's fiscal year ends on December 31.

Form Description Filed Period
6-K/A Form 6-k/a Oct 16, 2026 Aug 13, 2026
6-K Current report (foreign issuer) Sep 25, 2026 Sep 25, 2026
6-K Current report (foreign issuer) Sep 24, 2026 Sep 24, 2026
6-K Current report (foreign issuer) Aug 13, 2026 Aug 13, 2026
6-K Current report (foreign issuer) Jul 2, 2026 Jul 2, 2026
6-K Current report (foreign issuer) Jun 1, 2026 Jun 1, 2026
6-K Current report (foreign issuer) May 26, 2026 May 26, 2026
6-K Current report (foreign issuer) May 22, 2026 May 22, 2026
6-K Current report (foreign issuer) May 18, 2026 May 18, 2026
6-K Current report (foreign issuer) May 15, 2026 May 15, 2026
6-K Current report (foreign issuer) Apr 27, 2026 Apr 27, 2026
6-K Current report (foreign issuer) Mar 13, 2026 Mar 13, 2026
6-K Current report (foreign issuer) Feb 13, 2026 Feb 13, 2026
6-K Current report (foreign issuer) Feb 10, 2026 Feb 10, 2026
6-K Current report (foreign issuer) Jan 8, 2026 Jan 8, 2026

Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
NGEN (Nasdaq)
Fiscal year ends
December 31
Headquarters
Vancouver
SEC filer status
, Emerging growth company
SEC CIK
1751912

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.